Maxair

Active Ingredient(s): Pirbuterol
FDA Approved: * December 30, 1986
Pharm Company: * 3M
Category: Asthma

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Maxair Overview

Pirbuterol (trade name Maxair) is a short-acting β2 adrenoreceptor agonist with bronchodilating action used in the treatment of asthma, available (as pirbuterol acetate) as a breath-activated metered-dose inhaler. It was patented in 1971 and came into medical use in 1983.[1] Contents 1 Medical use 2 Mode of action 3 Pharmacokinetics 4 Adverse effects 5 References 6 External links Medical use Pirbuterol is used in asthma for reversal of acute bronchospasm, and also ...

Read more Maxair Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pirbuterol

Recent Maxair Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Pirbuterol
  • Aerosol, Metered: 0.2mg/actuation, 0.2mg/inh
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Pirbuterol or a similar ingredient: (1 result)